BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11737371)

  • 1. Molecular correlates in AIDS patients following antiretroviral therapy: diversified T-cell receptor repertoires and in vivo control of cytomegalovirus replication.
    Worrell S; Deayton J; Hayes P; Emery VC; Gotch F; Gazzard B; Larsson-Sciard EL
    HIV Med; 2001 Jan; 2(1):11-9. PubMed ID: 11737371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD4+ and CD8+ T cell receptor repertoire perturbations with normal levels of T cell receptor excision circles in HIV-infected, therapy-naive adolescents.
    Pahwa S; Chitnis V; Mitchell RM; Fernandez S; Chandrasekharan A; Wilson CM; Douglas SD
    AIDS Res Hum Retroviruses; 2003 Jun; 19(6):487-95. PubMed ID: 12882658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in CD4+ and CD8+ T cell subsets in response to highly active antiretroviral therapy in HIV type 1-infected patients with prior protease inhibitor experience.
    Gray CM; Schapiro JM; Winters MA; Merigan TC
    AIDS Res Hum Retroviruses; 1998 May; 14(7):561-9. PubMed ID: 9591710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in T-cell receptor Vbeta repertoire of CD4 and CD8 T lymphocytes in human immunodeficiency virus-infected children.
    Kharbanda M; McCloskey TW; Pahwa R; Sun M; Pahwa S
    Clin Diagn Lab Immunol; 2003 Jan; 10(1):53-8. PubMed ID: 12522039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective immunity to cytomegalovirus (CMV) retinitis in AIDS is associated with CMV-specific T cells that express interferon- gamma and interleukin-2 and have a CD8+ cell early maturational phenotype.
    Sinclair E; Tan QX; Sharp M; Girling V; Poon C; Natta MV; Jabs DA; Inokuma M; Maecker HT; Bredt B; Jacobson MA;
    J Infect Dis; 2006 Dec; 194(11):1537-46. PubMed ID: 17083038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diversity of the T-cell receptor BV repertoire in HIV-1-infected patients reflects the biphasic CD4+ T-cell repopulation kinetics during highly active antiretroviral therapy.
    Kostense S; Raaphorst FM; Notermans DW; Joling J; Hooibrink B; Pakker NG; Danner SA; Teale JM; Miedema F
    AIDS; 1998 Dec; 12(18):F235-40. PubMed ID: 9875570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal changes in CD4+ T cell antigen receptor diversity and naive/memory cell phenotype during 9 to 26 months of antiretroviral therapy of HIV-infected patients.
    Gea-Banacloche JC; Martino L; Mican JM; Hallahan CW; Baseler M; Stevens R; Lambert L; Polis M; Lane HC; Connors M
    AIDS Res Hum Retroviruses; 2000 Nov; 16(17):1877-86. PubMed ID: 11118073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subclinical Cytomegalovirus DNA Is Associated with CD4 T Cell Activation and Impaired CD8 T Cell CD107a Expression in People Living with HIV despite Early Antiretroviral Therapy.
    Christensen-Quick A; Massanella M; Frick A; Rawlings SA; Spina C; Vargas-Meneses M; Schrier R; Nakazawa M; Anderson C; Gianella S
    J Virol; 2019 Jul; 93(13):. PubMed ID: 31019052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiretroviral therapy restores diversity in the T-cell receptor Vbeta repertoire of CD4 T-cell subpopulations among human immunodeficiency virus type 1-infected children and adolescents.
    Yin L; Kou ZC; Rodriguez C; Hou W; Goodenow MM; Sleasman JW
    Clin Vaccine Immunol; 2009 Sep; 16(9):1293-301. PubMed ID: 19605599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower CD4+ T lymphocyte nadirs may indicate limited immune reconstitution in HIV-1 infected individuals on potent antiretroviral therapy: analysis of immunophenotypic marker results of AACTG 5067.
    D'Amico R; Yang Y; Mildvan D; Evans SR; Schnizlein-Bick CT; Hafner R; Webb N; Basar M; Zackin R; Jacobson MA
    J Clin Immunol; 2005 Mar; 25(2):106-15. PubMed ID: 15821887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A cross-sectional study on the effect of virological response after HAART on subsets of T lymphocytes and expression of CD127 in pediatric AIDS patients with different viral loads].
    Wu LJ; Wu LX; Bai S
    Zhonghua Er Ke Za Zhi; 2013 Sep; 51(9):659-64. PubMed ID: 24330984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of naïve (CD45RA+) and memory (CD45RO+) T-cells in HIV-infected Puerto Rican population.
    Roman M; Rodriguez JW; Pagán NO; Rios-Olivares E; Amill A; Hunter R
    P R Health Sci J; 2002 Sep; 21(3):195-201. PubMed ID: 12243109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination antiretroviral therapy results in a rapid increase in T cell receptor variable region beta repertoire diversity within CD45RA CD8 T cells in human immunodeficiency virus-infected children.
    Kou ZC; Puhr JS; Wu SS; Goodenow MM; Sleasman JW
    J Infect Dis; 2003 Feb; 187(3):385-97. PubMed ID: 12552422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normal CD4 T-cell receptor repertoire in tonsillar tissue despite perturbed repertoire in peripheral blood in HIV-1 infected individuals.
    Mugnaini EN; Syversen AM; Sannes M; Freng A; Brinchmann JE
    AIDS; 1999 Dec; 13(18):2507-13. PubMed ID: 10630519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dynamics of T lymphocyte subsets in HAART treated AIDS patients with successful suppression of HIV replication and different CD4 + T cell restoration].
    Qiu ZF; Li TS; Ruan GR; Han Y; Xie J; Zuo LY; Li YL; Wang AX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):386-90. PubMed ID: 16900640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poor predictive value of cytomegalovirus (CMV)-specific T cell assays for the development of CMV retinitis in patients with AIDS.
    Jacobson MA; Tan QX; Girling V; Poon C; Van Natta M; Jabs DA; Inokuma M; Maecker HT; Bredt B; Sinclair E;
    Clin Infect Dis; 2008 Feb; 46(3):458-66. PubMed ID: 18173357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of CD8 T cell clonal dominance in response to change in antiretroviral therapy in HIV-infected children.
    Kharbanda M; Than S; Chitnis V; Sun M; Chavan S; Bakshi S; Pahwa S
    AIDS; 2000 Oct; 14(15):2229-38. PubMed ID: 11089610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation for two-year highly active antiretroviral therapy in Chinese HIV-1 infection patients].
    Li H; Zheng YH; Shen Z; Liu M; Liu C; He Y; Chen J; Ou QY; Huang ZL
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(42):2973-6. PubMed ID: 18261327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact on the immune system of undetectable plasma HIV-1 RNA for more than 2 years.
    Arnó A; Ruiz L; Juan M; Zayat MK; Puig T; Balagué M; Romeu J; Pujol R; O'Brien WA; Clotet B
    AIDS; 1998 May; 12(7):697-704. PubMed ID: 9619800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterizing the immune system after long-term undetectable viral load in HIV-1-infected children.
    Resino S; Galán I; Bellón JM; Navarro ML; León JA; Muñoz-Fernandez MA
    J Clin Immunol; 2003 Jul; 23(4):279-89. PubMed ID: 12959220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.